CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
Normal Diet +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03341052
NCT03341052N/ACompleted
CompareCT.gov

Characterization of Bile Acid Pathway in Obesity

Mayo Clinic·interventional·Posted Nov 14, 2017·Updated Apr 27, 2023

In Brief

A clinical study evaluating Normal Diet, High Fat Diet, and 1 other intervention for Obesity. Completed, enrolled 16 participants across 1 site.

Detailed Summary

It is unknown whether the bile acid pathway is altered in obesity. This study is designed to compare obesity and health to determine if the bile acid pathway differs depending on health state.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 14, 2017
Enrollment StartNov 14, 2017
Primary CompletionOct 9, 2021
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 8.6 years ago

Interventions

Normal Dietother

The normal diet will consist of the participants' normal eating habits, and will be tracked by a food log. The participants will be on their normal diet during week 1 and week 3.

High Fat Dietother

The high fat diet will consist of 2700 kcal, 100g total fat (33%), 300mg cholesterol, 350g carbohydrates (52%), and 100g protein (15%). The participants will be on this diet during week 2.

Low Fat Dietother

The low fat diet will consist of 1200 kcal, 26g fat (20%), 78mg cholesterol, 150g carbohydrates (50%), and 100g protein (30%). The participants will be on this diet during week 4.